Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07129837) titled 'Serum Anti-PCOLCE as Novel Diagnostic Biomarker in Rheumatoid Arthritis With Emphasis on Seronegative Patients' on Aug. 12.

Study Type: Observational [Patient Registry]

Primary Sponsor: Assiut University

Condition: Rheumatoid Arthritis Anti-pcolce

Intervention: Diagnostic Test: Clinical evaluation, disease activity and disability scoring, and laboratory testing including RF, anti-CCP, and serum anti-PCOLCE antibody measurement by ELISA.

Recruitment Status: Not recruiting

Date of First Enrollment: May 2026

Target Sample Size: 62

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07129837

Published ...